Fulltext

Nipah@20: Lessons Learned from Another Virus with Pandemic Potential

Gómez Román R 1 , Wang LF 2 , Lee B 3 , Halpin K 4 , de Wit E 5 , Broder CC 6 Show all authors , Rahman M 7 , Kristiansen P 8 , Saville M 8

Affiliations 

  • 1 Coalition for Epidemic Preparedness and Innovations (CEPI), Oslo, Norway [email protected] [email protected]
  • 2 Duke-NUS Medical School, Singapore
  • 3 Icahn School of Medicine at Mount Sinai, New York, New York, USA [email protected] [email protected]
  • 4 Australian Centre for Disease Preparedness (ACDP), Geelong, Australia
  • 5 Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Hamilton, Montana, USA
  • 6 Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA
  • 7 Independent Consultant, Dhaka, Bangladesh
  • 8 Coalition for Epidemic Preparedness and Innovations (CEPI), Oslo, Norway
mSphere, 2020 07 08;5(4).
PMID: 32641430 DOI: 10.1128/mSphere.00602-20

Abstract

Nipah disease is listed as one of the WHO priority diseases that pose the greatest public health risk due to their epidemic potential. More than 200 experts from around the world convened in Singapore last year to mark the 20th anniversary of the first Nipah virus outbreaks in Malaysia and Singapore. Most of these experts are now involved in responding to the coronavirus disease 2019 (COVID-19) pandemic. Here, members of the Organizing Committee of the 2019 Nipah Virus International Conference review highlights from the Nipah@20 Conference and reflect on key lessons learned from Nipah that could be applied to the understanding of the COVID-19 pandemic and to preparedness against future emerging infectious diseases (EIDs) of pandemic potential.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications